Deleterious Action of Vasopressin in Gastroduodenal Ulceration: Experimental and Clinical Observations

REFERENCES

• Michell RH, Kirk CJ, Billah MM. Hormonal stimulation of phosphatidyl-inositol breakdown, with particular reference to the hepatic effect of vasopressin. Biochem Soc Trans 1979;7:861–5.
   Google Scholar
• Robertson GL. Posterior pituitary. In: Baxter JD, editor. Endocrinology and Metabolism, 2nd ed. New York: McGrawHill, 1987. p. 335–67.
   Google Scholar
• Reichlin S. Neuroendocrinology. In: Williams RH, editor. Textbook of endocrinology. Philadelphia, London, Toronto: WB Saunders, 1985. p. 492–567.
   Google Scholar
• Burnstock G. Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens 1990;Suppl 8:S95–106.
   Google Scholar
• Bodin P, Miller P, Marshall J, Burnstock J. Cytokines suppress the share stress-stimulated release of vasoactive mediators from human endothelial cells. Peptides 1995;16:1433–8.
   PubMed Web of Science ®Google Scholar
• Lincoln J, Loesch A, Burnstock G. Localisation of vasopressin, serotonin and angiotensin II in endothelial cells of the renal and mesenteric arteries of the rat. Cell Tissue Res 1990;259:341–4.
   Google Scholar
• Hourani SMO, Cusack NJ. Pharmacological receptors on blood platelets. Pharmacol Rev 1991;43:243–98.
   PubMed Web of Science ®Google Scholar
• Filep J, Rosenkranz B. Mechanism of vasopressin-induced platelet aggregation. Thromb Res 1987;45:7–15.
   PubMed Web of Science ®Google Scholar
• Wun T, Paglieroni T, Lachant NA. Physiologic concentrations of arginine vasopressin activate human platelets in vitro. Br J Haematol 1996;92:968–72.
   PubMed Web of Science ®Google Scholar
• Liard JF, Deriaz O, Schelling P, Thibonnier M. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs. Am J Physiol 1982;243:H663–9.
   PubMed Web of Science ®Google Scholar
• Share L. Role of vasopressin in cardiovascular regulation. Physiol Rev 1988;68:1248–84.
   PubMed Web of Science ®Google Scholar
• McNeill JR. Role of vasopressin in the control of arterial pressure. Can J Physiol Pharmacol 1983;61:1226–35.
   PubMed Web of Science ®Google Scholar
• Gardiner SM, Compton AM, Bennett T. Regional haemodynamic effects of vasopressin in conscious, unrestrained Brattleboro rat. Br J Pharmacol 1989;97:147–52.
   Google Scholar
• Köhler M, Weidig J-U. Role of desmopressin and vasopressin in haemostasis. In: Gross P, Richter D, Robertson GL, editors.Vasopressin. Proceedings of the Fourth International Vasopressin Conference. Paris: John Libbey Eurotext, 1993. p. 441–54.
   Google Scholar
• Manning M, Sawyer WH. Synthesis and receptor specificities of vasopressin antagonists. J Cardiovasc Pharmacol 1986;Suppl 7:S29–35.
   Google Scholar
• László FA, László F, De Wied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 1991; 43:73–108.
   PubMed Web of Science ®Google Scholar
• László FA, László F. Clinical perspectives for vasopressin antagonists. DN&P 1993;6:591–9.
   Google Scholar
• Tamura Y, Tahara A, Aoki M, et al. Pharmacological profile of YM087, a nonpeptide vasopressin antagonist in rats. In: Abstract Book, First Joint World Congress of Neurohypophysis and Vasopressin, 16–21 July 1995, Nasu, Tochigi, Japan, 1995. p. 142.
   Google Scholar
• Yamamura Y, Ogawa H, Chihara T, et al. OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Science 1991;252:572–4.
   PubMed Web of Science ®Google Scholar
• Serradeil-Le Gal C. Biochemical and pharmacological properties of SR 49059, a new, potent, non-peptide antagonist of rat and human vasopressin V1a receptors. J Clin Invest 1993;92: 224–31.
   PubMed Web of Science ®Google Scholar
• Sokol HW, Valtin H. The Brattleboro rat. Ann NY Acad Sci 1982;394:1–828.
   Web of Science ®Google Scholar
• Wyngaarden JB, Smith LH, Bennett JC, editors. Cecil textbook of medicine, 19th ed. Philadelphia: WB Saunders, 1992.
   Google Scholar
• St-Louis J, Schiffrin EL. Biological action and binding sites for vasopressin on the mesenteric artery from normal and sodium-depleted rats. Life Sci 1984;35:1489–95.
   Google Scholar
• Altura BM, Altura BT. Vascular smooth muscle and hypophyseal hormones. Fed Proc 1977;36:1853–60.
   PubMedGoogle Scholar
• Altura BM, Hershey SG, Zweifach BW. Effects of a synthetic analogue of vasopressin on vascular smooth muscle. Proc Soc Exp Biol Med 1965;119:258–61.
   PubMed Web of Science ®Google Scholar
• Cowley AW, Quillen EW, Skelton MM. Role of vasopressin in cardiovascular regulation. Fed Proc 1983;42:3170–6.
   Google Scholar
• László F, Karácsony G, Szabó E, Láng J, Baláspiri L, László FA. The role of vasopressin in the pathogenesis of ethanol-induced gastric hemorrhagic erosions in rats. Gastroenterology 1991;101:1242–8.
   PubMed Web of Science ®Google Scholar
• Kowalewski K. Protective action of vasopressin on posthistaminic gastric ulcers in guinea pigs, dogs and rats. In: Gheorghiu T, editor. Experimental ulcer. Baden-Baden, Brussels, Cologne: Gerhard Witzstrock Publisher, 1975. p. 105–10.
   Google Scholar
• Ritchie WP. Acute gastric mucosal damage induced by bile salts, acid and ischemia. Gastroenterology 1975;68:699–707.
   PubMed Web of Science ®Google Scholar
• Kivilaakso E, Fromm D, Silen W. Relationship between ulceration and intramural pH of gastric mucosa during hemorrhagic shock. Surgery 1978;84:70–8.
   Google Scholar
• Leung FW, Itoh H, Hirabayashi K, Guth PH. Role of blood flow in gastric and duodenal mucosal injury in the rat. Gastroenterology 1985;88:281–9.
   PubMed Web of Science ®Google Scholar
• Robert A, Kauffman GL. Stress ulcers, erosions, and gastric mucosal injury. In: Sleisenger MH, Fordtran JS, editors. Gastrointestinal disease, pathophysiology, diagnosis, management. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: WB Saunders, 1989. p. 772–95.
   Google Scholar
• Pang CCY. Effect of vasopressin antagonist and saralasin on regional blood flow following hemorrhage. Am J Physiol 1983;245:H749–55.
   PubMed Web of Science ®Google Scholar
• Nadasy GL, Szekacs B, Juhasz I, Monos E. Pharmacological modulation of prostacyclin and thromboxane production of rat and cat venous tissue slices. Prostaglandins 1992;44:339–55.
   PubMed Web of Science ®Google Scholar
• Wise WC, Cook JA, Halushka PV, Knapp DR. Protective effects of thromboxane synthase inhibitors in rats in endotoxic shock. Circ Res 1980;46:845–9.
   Web of Science ®Google Scholar
• Halushka PV, Cook JA, Wise WC. Beneficial effects of UK37248, a thromboxane synthase inhibitor, in experimental endotoxic shock in the rat. Br J Clin Pharmacol 1983;15 Suppl 1:133S–9S.
   Google Scholar
• Olanoff LS, Cook SA, Eller T, Knapp DR, Halushka PV. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxaemia. J Cardiovasc Pharmacol 1985;7: 114–20.
   Google Scholar
• Boughton-Smith NK, Hutcheson I, Whittle BJR. Relationship between paf-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins 1989;38: 319–33.
   Google Scholar
• Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 1987;46:133–8.
   PubMedGoogle Scholar
• László F, Whittle BJR, Moncada S. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol 1994;113: 1131–6.
   Google Scholar
• Dóczi T, Szerdahelyi P, Gulya K, Kiss J. Brain water accumulation after the central administration of vasopressin. Neurosurgery 1982;11:402–6.
   Google Scholar
• Rosenberg GA, Kyner WT, Fenstermacher JD, Patlak CS. Effectof vasopressin on ependymal and capillary permeability to tritiated water in cat. Am J Physiol 1986;251:F485–9.
   PubMed Web of Science ®Google Scholar
• Mózsik Gy, Jávor T. A biochemical and pharmacological approach to the genesis of ulcer disease. Dig Dis Sci 1988;33:92–105.
   PubMed Web of Science ®Google Scholar
• László F, Karácsony G, Pavo I, Varga Cs, Rojik I, László FA. Aggressive role of vasopressin in development of different gastric lesions in rats. Eur J Pharmacol 1994;258:15–22.
   PubMed Web of Science ®Google Scholar
• Friedmann AS, Memoli VA, Cheng SWT, Yu X, North WG. Vasopressin and vasopressin-associated neurophysin are present in gastric and duodenal cells of Brattleboro and Long-Evans rats. Ann NY Acad Sci 1993;689:522–5.
   Google Scholar
• Linkola J, Ylikahri R, Fyhrquist F, Wallenius M. Plasma vasopressin in ethanol intoxication and hangover. Acta Physiol Scand 1987;104:180–7.
   Google Scholar
• László F, Amani E, Karácsony G, Szabo E, Rengei B, Varga Cs, et al. The modulatory role of endogenous vasopressin in the phenomenon that orally administered ethanol generates more severe gastric erosions in male than in female rats. Ann NY Acad Sci 1993;689:623–6.
   Google Scholar
• Husain MK, Manger WM, Rock TW, Weiss RJ, Frantz AG. Vasopressin release due to manual restraint in the rat: role of body compression and comparison with other stressful stimuli. Endocrinology 1979;104:641–4.
   Google Scholar
• Iványi T, Wiegant VM, De Wied D. Differential effects of emotional stress and physical stress on the central and peripheral secretion of neurohypophyseal hormones in male rats. Life Sci 1991;48:1309–16.
   Google Scholar
• Aravich PF, Downing SN, Stanley EZ, Rieg TS, Doerries LE. Activity-stress ulcers are associated with increased gastric mucosal vasopressin content. Ann NY Acad Sci 1993;689: 461–4.
   Google Scholar
• László F, Amani E, Kaveh S, Nafradi J, Karácsony G, László FA. A vasopressin pressor receptor antagonist protects the rat gastric mucosa in the ethanol, reserpine, cold–restraint stress and indomethacin-induced ulcer models. Eur J Pharmacol 1990; 183:303–4.
   Google Scholar
• László F, Szepes Z, Karácsony G, Varga Cs, László FA. Endogenous vasopressin damages duodenal mucosa during haemorrhagic shock in rats. Inflammopharmacology 1996;4: 379–85.
   Google Scholar
• László F, Varga Cs, Karácsony G, Whittle BJR, László FA. Involvement of endogenous vasopressin in endotoxin-induced acute gastrointestinal injury in the rat. Gut 1993;34:S61.
   Google Scholar
• László F, Whittle BJR. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia. Eur J Pharmacol 1994;260:265–8.
   Google Scholar
• Jacobson ED, Swan KG, Grossman MI. Blood flow and secretion in the stomach. Gastroenterology 1967;52:414–20.
   Google Scholar
• Druge G, Raedler A, Greten H, Lenz HJ. Pathways mediating CRF-induced inhibition of gastric acid secretion. Am J Physiol 1989;256:G214–9.
   PubMed Web of Science ®Google Scholar
• László F, Szepes Z, Kiss J, Molnar T, Lonovics J, Boda K, et al. Aggressive role of vasopressin in human gastroduodenal ulceration. Dig Dis Sci 1996.
   Google Scholar
• László F, Whittle BJR. Colonic microvascular integrity in acute endotoxaemia: interactions between constitutive nitric oxide and 5-lipoxygenase products. Eur J Pharmacol 1995;277:R1–3.
   Google Scholar
• Ben-Menachem T, Fogel R, Patel RV, Touchette M, Zarowitz BJ, Hadzijahic N, et al. Prophylaxis for stress-related gastric hemorrhage in the intensive care unit. Ann Intern Med 1994;121:568–74.
   Google Scholar